These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 17027613)

  • 21. Insulated hsp70B' promoter: stringent heat-inducible activity in replication-deficient, but not replication-competent adenoviruses.
    Rohmer S; Mainka A; Knippertz I; Hesse A; Nettelbeck DM
    J Gene Med; 2008 Apr; 10(4):340-54. PubMed ID: 18265421
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Non-viral vectors in cystic fibrosis gene therapy: recent developments and future prospects.
    Pringle IA; Hyde SC; Gill DR
    Expert Opin Biol Ther; 2009 Aug; 9(8):991-1003. PubMed ID: 19545217
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The "grand" problem of synthetic delivery.
    Wolff JA
    Nat Biotechnol; 2002 Aug; 20(8):768-9. PubMed ID: 12147992
    [No Abstract]   [Full Text] [Related]  

  • 24. Therapeutic prospects of cardiac gene transfer.
    Kizana E
    Heart Lung Circ; 2007 Jun; 16(3):180-4. PubMed ID: 17446126
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cutaneous gene therapy.
    Jensen TG
    Ann Med; 2007; 39(2):108-15. PubMed ID: 17453674
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genetic modification of cells for transplantation.
    Lai Y; Drobinskaya I; Kolossov E; Chen C; Linn T
    Adv Drug Deliv Rev; 2008 Jan; 60(2):146-59. PubMed ID: 18037530
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The potential of oligonucleotides for therapeutic applications.
    Fichou Y; Férec C
    Trends Biotechnol; 2006 Dec; 24(12):563-70. PubMed ID: 17045686
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Advances in human artificial chromosome technology.
    Larin Z; Mejía JE
    Trends Genet; 2002 Jun; 18(6):313-9. PubMed ID: 12044361
    [TBL] [Abstract][Full Text] [Related]  

  • 29. OuaSelect, a novel ouabain-resistant human marker gene that allows efficient cell selection within 48 h.
    Treschow A; Unger C; Aints A; Felldin U; Aschan J; Dilber MS
    Gene Ther; 2007 Nov; 14(22):1564-72. PubMed ID: 17898799
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Recent advances in the development of oncolytic HSV-1 vectors: 'arming' of HSV-1 vectors and application of bacterial artificial chromosome technology for their construction.
    Jeyaretna DS; Kuroda T
    Curr Opin Mol Ther; 2007 Oct; 9(5):447-66. PubMed ID: 17932809
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Naturally occurring minichromosome platforms in chromosome engineering: an overview.
    Raimondi E
    Methods Mol Biol; 2011; 738():41-56. PubMed ID: 21431718
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gene therapy for cystic fibrosis lung disease: current status and future perspectives.
    Rosenecker J; Huth S; Rudolph C
    Curr Opin Mol Ther; 2006 Oct; 8(5):439-45. PubMed ID: 17078386
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Telomerase-mediated life-span extension of human primary fibroblasts by human artificial chromosome (HAC) vector.
    Shitara S; Kakeda M; Nagata K; Hiratsuka M; Sano A; Osawa K; Okazaki A; Katoh M; Kazuki Y; Oshimura M; Tomizuka K
    Biochem Biophys Res Commun; 2008 May; 369(3):807-11. PubMed ID: 18328257
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Applications of adenoviral vector-mediated gene transfer in cardiovascular research.
    Xu F; Serra D; Amalfitano A
    Methods Mol Med; 2006; 129():209-39. PubMed ID: 17085814
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A simple, lanthanide-based method to enhance the transduction efficiency of adenovirus vectors.
    Palmer GD; Stoddart MJ; Gouze E; Gouze JN; Ghivizzani SC; Porter RM; Evans CH
    Gene Ther; 2008 Mar; 15(5):357-63. PubMed ID: 18283289
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Targeted gene delivery to the lung.
    Aneja MK; Geiger JP; Himmel A; Rudolph C
    Expert Opin Drug Deliv; 2009 Jun; 6(6):567-83. PubMed ID: 19450167
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Modalities and future prospects of gene therapy in heart transplantation.
    Vassalli G; Roehrich ME; Vogt P; Pedrazzini GB; Siclari F; Moccetti T; von Segesser LK
    Eur J Cardiothorac Surg; 2009 Jun; 35(6):1036-44. PubMed ID: 19318274
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lack of toxicity of alpha-sarcoglycan overexpression supports clinical gene transfer trial in LGMD2D.
    Rodino-Klapac LR; Lee JS; Mulligan RC; Clark KR; Mendell JR
    Neurology; 2008 Jul; 71(4):240-7. PubMed ID: 18525034
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gene therapy protocols volume 2: design and characterization of gene transfer vectors. Preface.
    Le Doux JM
    Methods Mol Biol; 2008; 434():v. PubMed ID: 18700327
    [No Abstract]   [Full Text] [Related]  

  • 40. SIVMAC Vpx improves the transduction of dendritic cells with nonintegrative HIV-1-derived vectors.
    Berger G; Goujon C; Darlix JL; Cimarelli A
    Gene Ther; 2009 Jan; 16(1):159-63. PubMed ID: 18668143
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.